Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 15.52% |
| A M R CP | AAMRQ | 10.36% |
| MAXWELL TECH | MXWL | 6.19% |
| OLD SECOND B | OSBC | 4.54% |
| RADIANT LOGI | RLGT | 4.50% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Company Description
Orbotech provides production solutions for specific applications in electronics supply chain. Automatic check reading products and optical inspection products are just a few of the specialized offerings from the company.
Revenue spikes 47%
On Nov 1 Orbotech announced third-quarter results that included revenues of $158.1 million. That mark is up 8% over the previous third quarter, but the top line for the first 9 months of the year has swelled 47% to $405 million.
Earnings per share flew past expectations, coming in at 61 cents compared to the consensus of 17 cents. Orbotech has beat forecasts in each of the past 7 quarters.
The company also guided higher in the earnings release. Revenue is expected to be about $525 million, up from between $500 and $510 million.
Sold Unit for $9 million
Orbotech sold its medical systems business to General Electric (GE) for $9 million guaranteed and up to $5 million more for performance.
Estimates Jump
The Zacks Consensus Estimate for 2010 is up 16 cents, to 94 cents. Next year's forecasts are up 19 cents on average, to $1.17. Compare these marks to a 9-cent loss in 2009 and you have an excellent growth story.
The Chart
Shares of ORBK soared on the earnings news and have held this elevated level quite well. It looks like we may be seeing even higher levels sooner than later.
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Small Cap Trader service
Read the full Snapshot Report on ORBK